Sarada Gummadi, MD - Medicare Internal Medicine in Edinburg, TX

Sarada Gummadi, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Edinburg, Texas. She graduated from medical school in 2001 and has 23 years of diverse experience with area of expertise as Internal Medicine. She is a member of the group practice Renaissance Medical Foundation and her current practice location is 2717 Michaelangelo Dr Ste 200, Edinburg, Texas. You can reach out to her office (for appointments etc.) via phone at (956) 362-2250.

Sarada Gummadi is licensed to practice in Texas (license number M2965) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1740235662.

Contact Information

Sarada Gummadi, MD
2717 Michaelangelo Dr Ste 200,
Edinburg, TX 78539-1412
(956) 362-2250
(956) 362-2251



Physician's Profile

Full NameSarada Gummadi
GenderFemale
SpecialityInternal Medicine
Experience23 Years
Location2717 Michaelangelo Dr Ste 200, Edinburg, Texas
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Sarada Gummadi graduated from medical school in 2001
  NPI Data:
  • NPI Number: 1740235662
  • Provider Enumeration Date: 05/23/2006
  • Last Update Date: 11/03/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 2163434184
  • Enrollment ID: I20060612000180

Medical Identifiers

Medical identifiers for Sarada Gummadi such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1740235662NPI-NPPES
181141603MedicaidTX
181141602MedicaidTX
181141601MedicaidTX

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RH0003XInternal Medicine - Hematology & Oncology M2965 (Texas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Doctors Hospital At RenaissanceEdinburg, TXHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Renaissance Medical Foundation115340986786

News Archive

SPIRIT III trial shows fewer major adverse cardiac events

Late breaking results from the SPIRIT III trial, presented at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation, show that after 12 months, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent.

New poll reflects views on Palin and abortion; Abortion clinic protests planned

Most American women don't trust Mama Grizzly on abortion, birth control and sex ed, a new poll obtained by POLITICO shows. The survey, conducted for Planned Parenthood by Democratic pollster Hart Research Associates, found that just 24 percent of registered voters choose Sarah Palin as trustworthy on women's health issues, versus 54 percent who consider Planned Parenthood trustworthy (Kliff, 12/6).

Scientists looking for 480 people to test experimental anthrax vaccine

Scientists in Rochester and 11 other cities around the nation are beginning tests of an experimental vaccine aimed at protecting people against anthrax, a rare disease that, like smallpox, has become more threatening with the emergence of bioterrorism.

Severe retinal hemorrhaging in young children linked to severe motor vehicle crashes

The severity of retinal hemorrhaging for young children in motor vehicle crashes is closely correlated to the severity of the crash, according to a new study by researchers at the Medical College of Wisconsin in Milwaukee. Retinal hemorrhages occur when the blood vessels lining the retina rupture, resulting in bleeding onto the surface of the retina.

FDA approves Rituxan-FC combination therapy for CLL

Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec announced today the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide (FC) for people with previously untreated and previously treated CD20-positive chronic lymphocytic leukemia (CLL).

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sarada Gummadi allows following entities to bill medicare on her behalf.
Entity NameRenaissance Medical Foundation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1467633867
PECOS PAC ID: 1153409867
Enrollment ID: O20080422000326

News Archive

SPIRIT III trial shows fewer major adverse cardiac events

Late breaking results from the SPIRIT III trial, presented at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation, show that after 12 months, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent.

New poll reflects views on Palin and abortion; Abortion clinic protests planned

Most American women don't trust Mama Grizzly on abortion, birth control and sex ed, a new poll obtained by POLITICO shows. The survey, conducted for Planned Parenthood by Democratic pollster Hart Research Associates, found that just 24 percent of registered voters choose Sarah Palin as trustworthy on women's health issues, versus 54 percent who consider Planned Parenthood trustworthy (Kliff, 12/6).

Scientists looking for 480 people to test experimental anthrax vaccine

Scientists in Rochester and 11 other cities around the nation are beginning tests of an experimental vaccine aimed at protecting people against anthrax, a rare disease that, like smallpox, has become more threatening with the emergence of bioterrorism.

Severe retinal hemorrhaging in young children linked to severe motor vehicle crashes

The severity of retinal hemorrhaging for young children in motor vehicle crashes is closely correlated to the severity of the crash, according to a new study by researchers at the Medical College of Wisconsin in Milwaukee. Retinal hemorrhages occur when the blood vessels lining the retina rupture, resulting in bleeding onto the surface of the retina.

FDA approves Rituxan-FC combination therapy for CLL

Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec announced today the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide (FC) for people with previously untreated and previously treated CD20-positive chronic lymphocytic leukemia (CLL).

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sarada Gummadi is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Sarada Gummadi, MD
Po Box 749,
Pharr, TX 78577-1614

Ph: (956) 362-2250
Sarada Gummadi, MD
2717 Michaelangelo Dr Ste 200,
Edinburg, TX 78539-1412

Ph: (956) 362-2250

News Archive

SPIRIT III trial shows fewer major adverse cardiac events

Late breaking results from the SPIRIT III trial, presented at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation, show that after 12 months, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent.

New poll reflects views on Palin and abortion; Abortion clinic protests planned

Most American women don't trust Mama Grizzly on abortion, birth control and sex ed, a new poll obtained by POLITICO shows. The survey, conducted for Planned Parenthood by Democratic pollster Hart Research Associates, found that just 24 percent of registered voters choose Sarah Palin as trustworthy on women's health issues, versus 54 percent who consider Planned Parenthood trustworthy (Kliff, 12/6).

Scientists looking for 480 people to test experimental anthrax vaccine

Scientists in Rochester and 11 other cities around the nation are beginning tests of an experimental vaccine aimed at protecting people against anthrax, a rare disease that, like smallpox, has become more threatening with the emergence of bioterrorism.

Severe retinal hemorrhaging in young children linked to severe motor vehicle crashes

The severity of retinal hemorrhaging for young children in motor vehicle crashes is closely correlated to the severity of the crash, according to a new study by researchers at the Medical College of Wisconsin in Milwaukee. Retinal hemorrhages occur when the blood vessels lining the retina rupture, resulting in bleeding onto the surface of the retina.

FDA approves Rituxan-FC combination therapy for CLL

Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec announced today the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide (FC) for people with previously untreated and previously treated CD20-positive chronic lymphocytic leukemia (CLL).

Read more News

› Verified 2 days ago


Internal Medicine Doctors in Edinburg, TX

Daniela Hernandez, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 5423 S Mccoll Rd, Edinburg, TX 78539
Phone: 956-362-3575    Fax: 956-362-3584
Dr. Carlos Javier Cardenas, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 5520 Leonardo Da Vinci, Ste 100, Edinburg, TX 78539
Phone: 956-362-3636    Fax: 956-362-2699
Chi Lun Pui, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 2821 Michael Angelo, Ste. 400, Edinburg, TX 78539
Phone: 956-362-3553    
Dr. Brandon Robert Cantazaro, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 5423 S Mccoll Rd, Edinburg, TX 78539
Phone: 956-362-3575    Fax: 956-362-3584
Dr. Roque Masaharu Mifuji Lira, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539
Phone: 956-362-3553    Fax: 956-362-3584
James Walter Castillo Ii, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539
Phone: 956-362-8677    Fax: 956-362-7253
Nevin Antony Varghese, M.D
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 5423 S Mccoll Rd, Edinburg, TX 78539
Phone: 956-362-3575    Fax: 956-362-3575

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.